The Drug Enforcement Agency's Position on "Constructive Transfer" Under the Controlled Substances Act

Author(s):  Pore R David

Issue:  Nov/Dec 2012 - Volume 16, Number 6
View All Articles in Issue

Abstract:  This article provides a summary of the Drug Enforcement Agency’s current interpretation of the Controlled Substances Act as it relates to the “constructive transfer” of certain controlled substances from pharmacist to physician for office administration. The article discusses compliance with the Controlled Substances Act in this context and related legislative and legal activities of individual pharmacists and of the International Academy of Compounding Pharmacists and other groups.

Related Keywords: R. David Pore, MA, JD, U.S. Drug Enforcement Agency, DEA, constructive transfer, Controlled Substances Act, DEA Form 222, compounded sterile preparations

Related Categories: LEGAL, PAIN MANAGEMENT, PROFESSIONAL ISSUES

Purchase this article for download in electronic PDF format from IJPC at for $75 at:
https://ijpc.com/Abstracts/Abstract.cfm?ABS=3555

Search the entire IJPC archive by keyword, topic, or issue at:
https://ijpc.com/Products